Research services
Naser Elkum
Our research team integrates advanced biostatistics, epidemiology, and multi-omics to transform complex data into actionable clinical insights.
Overview
Data analysis is our strength. Using the valuable insights gained through various analytical methods, we translate complex data into clinically actionable tools for early detection, precision risk stratification, and personalised prevention.
Research That Prioritises Prevention and Early Detection of Cancers Through Biomarkers
While cancer drugs can be life-saving, their lack of specificity can lead to unwanted toxicity and organ damage. Our research looks into other modes of therapy, like monoclonal antibodies and cytokines, that can be used in a targeted manner, effectively killing cancer cells while sparing healthy tissue. We also explore drug combinations that are more protective than traditional chemotherapy, in addition to discovering biomarkers that will help clinicians identify and treat the most aggressive forms of cancer.
Our Team
We are currently expanding our team with new scientists and research associates joining soon.
Naser Elkum
Scientist / Team Leader
Manal Rashid Almarzouqi
Clinical Research Coordinator
Projects
Our projects are focused on early disease detection, precision risk stratification, and personalised prevention strategies.
Beta Version